FBN2基因突变与遗传性结缔组织病的发生

doi:10.16288/j.yczz.19-052

[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2019, Vol. 41 ›› Issue (10): 919-927.doi: 10.16288/j.yczz.19-052

• Review • Previous Articles Next Articles

Fibrillin-2 gene mutations associated with hereditary connective tissue diseases

Furu Xu^1,²,Wenjun Jiang^2,³,Tao Zhang^1,^2,³,Qian Jiang^1,^2,³,Ruixue Zhang^1,^2,³,Hongsheng Bi^1,^2,^3,⁴()

^1. Shandong University of Traditional Chinese Medicine, Jinan 250014, China
^2. Shandong Pvovince Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Disease, Jinan 250002, China
^3. Institute of Shandong University of Traditional Chinese, Jinan 250002, China
^4. Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China

Received:2019-04-08 Revised:2019-05-30 Online:2019-10-20 Published:2019-06-03
Contact: Bi Hongsheng E-mail:hongshengbi@126.com
Supported by:
Supported by the National Natural Science Foundation of China No.(81603421);Shandong Province Key Research and Devlepment Program No.(2016GGH3119);Shandong Province Key Research and Devlepment Program No.(2017CXGC1211)

Abstract

Abstract:

Fibrillin-2 (FBN2) is an important component of microfibers which are involved in the formation of elastic fibers in connective tissue throughout the human body. Hereditary connective tissue diseases may result from genetic mutations of FBN2 causing heterogeneity of fibrin. Genetic mutations of FBN2 are associated with a variety of hereditary connective tissue diseases including Congenital Contractural Arachnodactyl (CCA), Macular Degeneration (MD), and myopathy. Studies have shown that the FBN2 gene is recognized as the only pathogenic gene related to CCA and that CCA patients have different clinical presentations depending on the identified genetic mutations at different FBN2 sites. In this review, we summarize the roles of FBN2, its mutations and impact on the physiological and pathological processes of many hereditary connective tissue diseases. We include brief descriptions of clinical manifestations of these diseases providing a basis for further exploration of the specific molecular mechanism of FBN2 gene mutation pathogenesis which provides a theoretical basis for the therapy and medications for refractory diseases caused by FBN2 gene mutation.

Key words: fibrillin-2, gene mutation, congenital contracture arachnoid, macular degeneration, genetic

Furu Xu, Wenjun Jiang, Tao Zhang, Qian Jiang, Ruixue Zhang, Hongsheng Bi. Fibrillin-2 gene mutations associated with hereditary connective tissue diseases[J]. Hereditas(Beijing), 2019, 41(10): 919-927.

References 36

[1]	Davis MR, Summers KM . Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases. Mol Genet Metab, 2012,107(4):635-647.
[2]	Center for Human Genetics , DNA test descriptions & CPT codes, http://chginc.org/dna-test-descriptions-cpt-codes/ .
[3]	Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, Tsipouras P, Ramirez F, Hollister DW . Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature, 1991,352(6333):330-334.
[4]	Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J, Mecham RP, Ramirez F . Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol, 1994,124(5):855-863.
[5]	Frédéric MY, Monino C, Marschall C, Hamroun D, Faivre L, Jondeau G, Klein HG, Neumann L, Gautier E, Binquet C, Maslen C, Godfrey M, Gupta P, Milewicz D, Boileau C, Claustres M, Béroud C, Collod-Béroud G . The FBN2 gene: new mutations, locus-specific database (universal mutation database fbn2), and genotype-phenotype correlations. Hum Mutat, 2010,30(2):181-190.
[6]	Trask TM, Ritty TM, Broekelmann T, Tisdale C, Mecham RP . N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly. Biochem J, 1999,340(Pt 3):693-701.
[7]	Ratnapriya R, Zhan X, Fariss RN, Branham KE, Zipprer D, Chakarova CF, Sergeev YV, Campos MM, Othman M, Friedman JS, Maminishkis A, Waseem NH, Brooks M, Rajasimha HK, Edwards AO, Lotery A, Klein BE, Truitt BJ, Li B, Schaumberg DA, Morgan DJ, Morrison MA, Souied E, Tsironi EE, Grassmann F, Fishman GA, Silvestri G, Scholl HP, Kim IK, Ramke J, Tuo J, Merriam JE, Merriam JC, Park KH, Olson LM, Farrer LA, Johnson MP, Peachey NS, Lathrop M, Baron RV, Igo RP Jr, Klein R, Hagstrom SA, Kamatani Y, Martin TM, Jiang Y, Conley Y, Sahel JA, Zack DJ, Chan CC, Pericak-Vance MA, Jacobson SG, Gorin MB, Klein ML, Allikmets R, Iyengar SK, Weber BH, Haines JL, Léveillard T, Deangelis MM, Stambolian D, Weeks DE, Bhattacharya SS, Chew EY, Heckenlively JR, Abecasis GR, Swaroop A . Rare and common variants in extracellular matrix gene fibrillin 2 (FBN2) are associated with macular degeneration. Hum Mol Genet, 2014,23(21):5827-5837.
[8]	You G, Zu B, Wang B, Wang Z, Xu Y, Fu Q . Exome sequencing identified a novel FBN2 mutation in a Chinese family with congenital contractural arachnodactyly. Int J Mol Sci, 2017,18(4):626-635.
[9]	Jensen SA, Iqbal S, Lowe ED, Redfield C, Handford PA . Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/tlbp superfamily of matrix proteins. Structure, 2009,17(5):759-768.
[10]	Meena JP, Gupta A, Mishra D, Juneja M . Beals-hecht syndrome (congenital contractural arachnodactyly) with additional craniospinal abnormality: a case report. J Pediatr Orthop B, 2015,24(3):226-229.
[11]	Chen QQ, Wu YA, Huang XL, Chen T, Huang Y, Chen FL, Chen FW . Analysis of two new mutations in FBN1 gene in Han people with Marfan syndrome (MFS). Genetics, 2010,32(1):49-53.
	陈清泉, 伍严安, 黄肖利, 陈同, 黄毅, 陈发林, 陈发文 . 汉族马凡综合征(MFS)患者FBN1基因两种新发突变分析. 遗传, 2010,32(1):49-53.
[12]	Gupta PA, Putnam EA, Carmical SG, Kaitila I, Steinmann B, Child A, Danesino C, Metcalfe K, Berry SA, Chen E, Delorme CV, Thong MK, Adès LC, Milewicz DM . Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat, 2002,19(1):39-48.
[13]	Guo X, Song C, Shi Y, Li H, Meng W, Yuan Q, Xue J, Xie J, Liang Y, Yuan Y, Yu B, Wang H, Chen Y, Qi L, Li X . Whole exome sequencing identifies a novel missense FBN2, mutation co-segregating in a four-generation chinese family with congenital contractural arachnodactyly. BMC Med Genet, 2016,17(1):91.
[14]	Deng H, Lu Q, Xu H, Deng X, Yuan L, Yang Z, Guo Y, Lin Q, Xiao J, Guan L, Song Z . Identification of a novel missense FBN2 Mutation in a chinese family with congenital contractural arachnodactyly using exome sequencing. PLoS One, 2016,11(5):e0155908.
[15]	Liu W, Zhao N, Li XF, Wang H, Sui Y, Lu YP, Feng WH, Ma C, Han WT, Jiang M . A novel FBN2 mutation in a chinese family with congenital contractural arachnodactyly. FEBS Open Bio, 2015,5:163-166.
[16]	Zhou S, Wang F, Dou Y, Zhou J, Hao G, Xu C, Wang QK, Wang H, Wang P . A novel mutation cosegregates with congenital contractural arachnodactyly in a five-generation chinese family. Clin Case Rep, 2018,6(8):1612-1617.
[17]	Chen Y, Lei YP, Zheng HX, Wang W, Cheng HB, Zhang J, Wang HY, Jin L, Li H . A novel mutation (C1425Y) in the FBN2 gene in a father and son with congenital contractural arachnodactyly. Genet Test Mol Bioma, 2009,13(3):295-300.
[18]	Gürler AI, Yüksel Z, Karaer K . A novel FBN2 mutation in a turkish case with congenital contractural arachnodactyly. Clin Dysmorphol, 2018,27(3):109-111.
[19]	Renner S, Schüler H, Alawi M, Kolbe V, Rybczynski M, Woitschach R, Sheikhzadeh S, Stark VC, Olfe J, Roser E, Seggewies FS, Mahlmann A, Hempel M, Hartmann MJ, Hillebrand M, Wieczorek D, Volk AE, Kloth K, Koch-Hogrebe M, Abou Jamra R, Mitter D, Altmüller J, Wey-Fabrizius A, Petersen C, Rau I, Borck G, Kubisch C, Mir TS, von Kodolitsch Y, Kutsche K, Rosenberger G . Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients. Genet Med, 2019. doi: 10.1038/s41436-019-0435-z
[20]	Takeda N, Morita H, Fujita D, Inuzuka R, Taniguchi Y, Imai Y, Hirata Y, Komuro I . Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: case report and review of literature. Am J Med Genet A, 2015,167(10):2382-2387.
[21]	Mehar V, Yadav D, Kumar R, Yadav S, Singh K, Callewaert B, Pathan S, De Paepe A, Coucke PJ . Congenital contractural arachnodactyly due to a novel splice site mutation in the FBN2 gene. J Pediatr Genet, 2014,03(03):163-166.
[22]	Inbar-Feigenberg M, Meirowitz N, Nanda D, Toi A, Okun N, Chitayat D . Beals syndrome (congenital contractural arachnodactyly): prenatal ultrasound findings and molecular analysis. Ultrasound Obstet Gynecol, 2015,44(4):486-490.
[23]	Lavillaureix A, Heide S, Chantot-Bastaraud S, Marey I, Keren B, Grigorescu R, Jouannic JM, Gelot A, Whalen S, Héron D, Siffroi JP . Mosaic intragenic deletion of FBN2 and severe congenital contractural arachnodactyly. Clin Genet, 2017,92(5):556-558.
[24]	Aggarwal S, Das Bhowmik A, Tandon A, Dalal A . Exome sequencing reveals blended phenotype of double heterozygous FBN1 and FBN2 variants in a fetus. Eur J Med Genet, 2018,61(7):399-402.
[25]	Duvvari MR, van de Ven JP, Geerlings MJ, Saksens NT, Bakker B, Henkes A, Neveling K, del Rosario M, Westra D, van den Heuvel LP, Schick T, Fauser S, Boon CJ, Hoyng CB, de Jong EK, den Hollander AI . Whole exome sequencing in patients with the cuticular drusen subtype of age-related macular degeneration. PLoS One, 2016,11(3):e0152047.
[26]	Shi Y, Tu Y, Mecham RP, Bassnett S . Ocular phenotype of fbn2-null mice. Invest Ophth Vis Sci, 2013,54(12):7163-7173.
[27]	Monies D, Maddirevula S, Kurdi W, Alanazy MH, Alkhalidi H, Al-Owain M, Sulaiman RA, Faqeih E, Goljan E, Ibrahim N, Abdulwahab F, Hashem M, Abouelhoda M, Shaheen R, Arold ST, Alkuraya FS . Autozygosity reveals recessive mutations and novel mechanisms in dominant genes: implications in variant interpretation. Genet Med, 2017,19(10):1144-1150.
[28]	Zhang H, Hu W, Ramirez F . Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol, 1995,129(4):1165-1176.
[29]	Miller G, Neilan M, Chia R, Gheryani N, Holt N, Charbit A, Wells S, Tucci V, Lalanne Z, Denny P, Fisher EM, Cheeseman M, Askew GN, Dear TN . ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2. PLoS One, 2010,5(2):e9137.
[30]	Sengle G, Carlberg V, Tufa SF, Charbonneau NL, Smaldone S, Carlson EJ, Ramirez F, Keene DR, Sakai LY . Abnormal activation of BMP signaling causes myopathy in fbn2 null mice. PLoS Genet, 2015,11(6):e1005340.
[31]	Yuan S, Xing XB, Xu SW, Jiang YR, Guo Y, Wang F, Zhao WN, Liu FS . A typical Stanford type B aortic dissection patient carries a FBN2 gene p.T2278M mutation in 1 case. J Clin Cardiol,2017, 33(12):1237-1239.
	袁帅, 刑晓博, 徐晟伟, 姜玉瑞, 郭勇, 王芳, 赵雯娜, 刘福颂 . 典型Stanford B型主动脉夹层患者携带FBN2基因p.T2278M突变1例. 临床心血管病杂志, 2017,33(12):1237-1239.
[32]	Kunnas T, Solakivi T, Nikkari ST . Gene polymorphisms of fibronectin rs2289202 and fibrillin 2 rs331069 associate with vascular disease, the TAMRISK study. Biomed Rep, 2018,8(1):65-68.
[33]	Khoury LE, Posthumus M, Collins M, Collins M, van der Merwe W, Handley C, Cook J, Raleigh SM . ELN and FBN2 gene variants as risk factors for two sports-related musculoskeletal injuries. Int J Sports Med, 2015,36(4):333-337.
[34]	Buchan JG, Alvarado DM, Haller GE, Cruchaga C, Harms MB, Zhang T, Willing MC, Grange DK, Braverman AC, Miller NH, Morcuende JA, Tang NL, Lam TP, Ng BK, Cheng JC, Dobbs MB, Gurnett CA . Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. Hum Mol Genet, 2014,23(19):5271-5282.
[35]	Ratschiller T, Müller H, Schachner T, Fellner F, Sulzbacher G, Zierer A . Femoral artery aneurysm repair in a patient with a fibrillin-2 mutation. Vasc Endovascular Surg, 2018,52(7):583-586.
[36]	Zhang JH, Guo Q, Zhou JZ, Zhang Y . Study on the correlation between FBN1/FBN2 gene methylation and esophageal carcinoma. J Mod Oncol, 2018,26(4):523-526.
	张建华, 郭琪, 周章剑, 张毅 . FBN1、FBN2基因甲基化与食管癌的相关性研究. 现代肿瘤医学, 2018,26(4):523-526.

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

Fibrillin-2 gene mutations associated with hereditary connective tissue diseases

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 36

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhong Bian, Dongping Cao, Wenshu Zhuang, Shuwei Zhang, Qiaoquan Liu, Lin Zhang. Revelation of rice molecular design breeding: the blend of tradition and modernity [J]. Hereditas(Beijing), 2023, 45(9): 718-740.
[2]	Jun Ma, Anping Fan, Wusheng Wang, Jinchuan Zhang, Xiaojun Jiang, Ruijun Ma, Sheqiang Jia, Fei Liu, Chuchao Lei, Yongzhen Huang. Analysis of genetic diversity and genetic structure of Qinchuan cattle conservation population using whole-genome resequencing [J]. Hereditas(Beijing), 2023, 45(7): 602-616.
[3]	Xiao Chen, Jian Lu, Fuqing Yu. Conservation of animal genetic resources in the world and its enlightenment to China [J]. Hereditas(Beijing), 2023, 45(7): 545-552.
[4]	Liang Jin, Yujie Chen, Yongjun Chen. Advances in genetic etiology, diagnosis and treatment of developmental and epileptic encephalopathy [J]. Hereditas(Beijing), 2023, 45(7): 553-567.
[5]	Juan Huang, Wenhua Miao, Xiaofeng Guo, Wei Ji. Diagnosis and genetic testing analysis of limb-girdle muscular dystrophy type 2U caused by a compound heterozygous mutation in the ISPD gene [J]. Hereditas(Beijing), 2023, 45(6): 536-542.
[6]	Yifan Yu, Zhen OuYang, Juan Guo, Yujun Zhao, Luqi Huang. Progress on regulatory elements of plant plastid genetic engineering [J]. Hereditas(Beijing), 2023, 45(6): 501-513.
[7]	Jie Ma, Lujie Huang, Qiaoxia Zhang, Yan Zhu, Lu Qian. PBL teaching design of medical genetics with the case of brachydactyly type A2 [J]. Hereditas(Beijing), 2023, 45(2): 176-183.
[8]	Beiping Zeng, Hongen Xu, Lu Mao, Wenxue Tang. Molecular diagnosis of hereditary deafness and application of stepwise testing strategy [J]. Hereditas(Beijing), 2023, 45(1): 29-41.
[9]	Fei Gao, Yu Wang, Jiaxiang Du, Xuguang Du, Jianguo Zhao, Dengke Pan, Sen Wu, Yaofeng Zhao. Advances and applications of genetically modified pig models in biomedical and agricultural field [J]. Hereditas(Beijing), 2023, 45(1): 6-28.
[10]	Tian Xie, Mei Wang, Ruiyu Gao, Yanni Miao, Yiming Zhang, Jing Jiang. Development and application of light-controlled inducible recombination systems [J]. Hereditas(Beijing), 2022, 44(8): 655-671.
[11]	Yan Zhao, Chenxin Wang, Tianming Yang, Chunshuang Li, Lihong Zhang, Dongni Du, Ruoxi Wang, Jing Wang, Min Wei, Xueqing Ba. Linking oxidative DNA lesion 8-OxoG to tumor development and progression [J]. Hereditas(Beijing), 2022, 44(6): 466-477.
[12]	Shaozheng Song, Zhengyi He, Yong Cheng, Baoli Yu, Ting Zhang, Dan Li. MSTN modification in goat mediated by TALENs and performance analysis [J]. Hereditas(Beijing), 2022, 44(6): 531-542.
[13]	Fei Wang, Meng Wang, Xinghua Zhang, Keli Yu, Lianbin Zheng, Yajun Yang. Genetic substructure analysis of three isolated populations in southwest China [J]. Hereditas(Beijing), 2022, 44(5): 424-431.
[14]	Jie Kou, Yan Li, Peng Wang, Hong Liu, Jiawen Liu, Juan Wang, Ye Wang, Liang Zhang, Fujun Shen. Optimization of microsatellite genotyping system used for genetic diversity evaluation of Ailuropoda melanoleuca [J]. Hereditas(Beijing), 2022, 44(3): 253-266.
[15]	Hui Qu, Yi Liu, Yawen Chen, Hui Wang. Alteration of imprinted genes and offspring organ development caused by environmental factors [J]. Hereditas(Beijing), 2022, 44(2): 107-116.